DOI: https://dx.doi.org/10.18203/2349-2902.isj20220951
Published: 2022-03-28

Strumma ovarii: a case report and literature review

Rodríguez-Juárez Irving Oswaldo, Moreno-Peña Pablo Jose, Méndez-Pérez Alan Amado, Avalos-Bishop Andres, Soule-Martinez Christian Enrique

Abstract


Struma ovarii is an uncommon monodermic teratoma in which thyroid tissue is the predominant element. Its low prevalence, wide age of presentation, variable clinical manifestations, and the lack of accurate diagnostic methods, contribute to the overall high percentage of misdiagnosis (90%). Surgery is the best available therapeutic option and the prognosis in most cases is good. This article summarizes the most relevant points for the diagnosis, management, and follow-up of this pathology.


Keywords


Strumma ovarii, Ovarian tumor, Teratoma, Papillary thyroid cancer

Full Text:

PDF

References


Aust S, Eberst L, Tredan O. Detailed overview on rare malignant ovarian tumors. Bull Cancer. 2020;107(3):385-90.

Saleh M, Bhosale P, Menias CO. Ovarian teratomas: clinical features, imaging findings and management. Abdom Radiol (NY). 2021;46(6):2293-307.

Kabukcuoglu F, Baksu A, Yilmaz B, Aktumen A, Evren I. Malignant struma ovarii. Pathol Oncol Res. 2002;8(2):145-7.

Talerman A. Blaustein's Pathology of the Female Genital Tract. 5th ed. Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. New York, NY, NY: Springer US. 2018-1391.

Goffredo P, Sawka AM, Pura J, Adam MA, Roman SA, Sosa JA. Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Thyroid. 2015;25(2):211-5.

Hatami M, Breining D, Owers RL, Del Priore G, Goldberg GL. Malignant struma ovarii--a case report and review of the literature. Gynecol Obstet Invest. 2008;65(2):104-7.

Young RH. New and unusual aspects of ovarian germ cell tumors. Am J Surg Pathol. 1993;17(12):1210-24.

Teale E, Gouldesbrough DR, Peacey SR. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies. Thyroid. 2006;16(8):791-3.

Savelli L, Testa AC, Timmerman D, Paladini D, Ljungberg O, Valentin L. Imaging of gynecological disease (4): clinical and ultrasound characteristics of struma ovarii. Ultrasound Obstet Gynecol. 2008;32(2):210-9.

Dardik RB, Dardik M, Westra W, Montz FJ. Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol. 1999;73(3):447-51.

Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ. Malignant struma ovarii. Gynecol Oncol. 1989;32(2):224-7.

Roth LM, Talerman A. The enigma of struma ovarii. Pathology. 2007;39(1):139-46.

Euscher ED. Germ Cell Tumors of the Female Genital Tract. Surg Pathol Clin. 2019;12(2):621-49.

Gobitti C, Sindoni A, Bampo C. Malignant struma ovarii harboring a unique NRAS mutation: case report and review of the literature. Hormones (Athens). 2017;16(3):322-7.

Bolat F, Erkanli S, Kayaselcuk F, Aslan E, Tuncer I. Malignant struma ovarii: a case report. Pathol Res Pract. 2005;201(5):409-12.

Carvalho JP, Carvalho FM, Lima de Oliveira FF, Asato de Camargo RY. Hypothyroidism following struma ovarii tumor resection: a case report. Rev Hosp Clin Fac Med Sao Paulo. 2002;57(3):112-4.

Volpi E, Ferrero A, Nasi PG, Sismondi P. Malignant struma ovarii: a case report of laparoscopic management. Gynecol Oncol. 2003;90(1):191-4.